Build with DKD Phoxis: science-first partnerships that scale
We partner across the full translational arc — from analytical characterization and RWD evidence, to manufacturing, licensing, and multi-site clinical deployment. Clear roles, clean documentation, and defensible IP.
Phospholipid Platform
Solvent-free extraction + characterization dossier roadmap for fund/grant review.
Evidence Pipeline
RWD registry → publishable RWE → pragmatic/hybrid trial templates.
Clinical Utility
Wound/epithelial care applications designed for routine-care settings.
Operational Discipline
Audit trail, version control, batch consistency approach, partner-ready SOPs.
Choose the model that fits your organization
We can start small (analytics + dossier) or expand into multi-site deployment. Each model can be structured with clear milestones and optional exclusivity boundaries.
Analytical + CMC-lite package
For federal grants, due-diligence, and early-stage validation without exposing trade secrets.
- 3 pilot batches: identity, purity, stability plan
- 31P-NMR, HPLC/UPLC, FA profile, PV/AV, KF water, metals, micro
- Dossier-ready report + raw data package (as available)
RWD registry → RWE study
For hospitals/clinics seeking structured outcomes in routine care (pragmatic-ready).
- Standard intake + photo protocol + endpoint rubric
- Ethics-ready documents (observational / hybrid designs)
- Safety monitoring + AE/SAE routing + reporting
Licensing / OEM / Distribution
For partners with manufacturing or go-to-market strength, built around strict IP boundaries.
- Territory & channel scope + milestone-based exclusivity
- Quality system alignment + batch release specs
- Royalty / supply / transfer terms + data governance
Optional add-ons
Increase strength for grants or advanced diligence.
- Advanced lipidomics fingerprint (molecular species signature)
- Accelerated stability (0–1–3–6 months) + packaging compatibility screen
- Multi-site training kit: SOPs, field guide, data dictionary, audit trail
A clean process built for speed and credibility
We prioritize rapid alignment, clear data ownership, and documentation that can be reused for grants and regulatory discussions.
Define scope & success metrics
Use-case, target indications, endpoints, batch count, timeline, and deliverables.
Contracting & governance
NDA → data ownership → IP boundaries → reporting format → milestone schedule.
Execution & documentation
Testing / registry deployment / clinical workflow + audit trail + version control.
Review & scale
Dossier-ready summary, publishable outputs, and expansion plan (sites/markets).
Can we start with a small, low-risk pilot?
Yes. Most partners begin with Model A (CMC-lite dossier) or a single-site RWD registry pilot to validate workflow before scaling.
Do we have to be exclusive?
No. Exclusivity is optional and should be milestone-based (e.g., after dossier completion or after IP filing) with clear territory and scope boundaries.
How is data ownership handled?
We define data ownership and use rights upfront. Typically: partner owns site data; DKD retains platform know-how; shared publication terms are agreed in writing.
What makes your documentation “grant-ready”?
Standardized endpoints, audit trail, version control, raw data retention, and a clear CMC-lite analytical panel tied to batch consistency and stability.
Tell us your use-case. We’ll propose a partnership plan in 48 hours.
Send your target indication, required tests or clinical scope, and timeline. We will reply with a structured plan: model, milestones, deliverables, and reporting format.